Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001209191-22-059579

Options or other derivatives

  • Director acquired 47,231 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hayden Michael R Director 2022-12-01 Grant or award · Share Option (right to buy) +47,231 497,045 D
Loading xslF345X03/doc4.xml…